Stock Futures Slightly Lower Amid Oil Price Volatility
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2026
0mins
Should l Buy HITI?
Stock futures were fractionally lower following marginal gains during Tuesday's session amid continuing conflict in Iran. Though oil ended up down for the session, it was trading higher earlier in the session once again following comments from President Trump on Monday, in which he suggested that a coalition to protect shipping along the Strait of Hormuz remains in the works, though he told reporters that some countries are "less than enthusiastic" about such plans. Meanwhile, investors continue to monitor further developments in Iran, particularly after Iran's security chief Ali Larijani was killed in airstrikes overnight, according to Israeli Defense Minister Israel Katz.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -High Tideup 8.4%ALSO HIGHER -Swarmerup 35.2% after its IPO opened at $12.50 per shareLOWER AFTER EARNINGS -Cibusdown 10.3%Lululemondown 1.6%ALSO LOWER -Intelligent Protectiondown 8.5% after filing to sell 9M shares of common stock for holders
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HITI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HITI
Wall Street analysts forecast HITI stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.320
Low
7.50
Averages
7.50
High
7.50
Current: 2.320
Low
7.50
Averages
7.50
High
7.50
About HITI
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include bricks-and-mortar, e-commerce and medical cannabis distribution. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries and supports the distribution of accessories and other items to the United States. The medical cannabis distribution segment includes the medical cannabis distribution operations. It offers a suite of proprietary brands which include Dopezilla, Atomik, Puff Puff Pass, Vodka Glass, Queen of Bud, and Cabana Cannabis Co. Canna Cabana is the Company’s primary retail cannabis business, offering the retail sale of various cannabis products and accessories through its provincially authorized cannabis retail store locations. Canna Cabana operates a retail cannabis chain with approximately 219 branded stores operating across Canada.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive program as a supplier of eligible CBD products, marking a significant step toward integrating CBD into healthcare models.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the program's compliance requirements, thereby enhancing its competitive position in the market.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per beneficiary, which is expected to create significant market opportunities for NuLeaf and drive growth in its U.S. CBD business.
- Strategic Collaboration: NuLeaf's founding membership in the National Compassionate Care Council further solidifies its strategic position in advancing evidence-based cannabinoid policy and improving patient access to cannabinoid therapies.
See More
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive pilot program as a supplier of eligible CBD products, marking a strategic expansion into the healthcare market that is expected to drive growth in High Tide's U.S. CBD business.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the compliance requirements of the pilot program, thereby enhancing its competitiveness within the healthcare sector.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per year, which is anticipated to create new revenue streams for NuLeaf and increase its market share.
- Industry Impact: The launch of this program is viewed as a historic moment for the U.S. CBD industry, potentially improving treatment options for millions of Medicare beneficiaries and further solidifying NuLeaf's leadership position in the sector.
See More
High Tide Reports Strong Q1 Earnings with 25% Revenue Growth
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million, a 25% year-over-year increase, marking the fastest growth rate in the past 10 quarters, indicating strong market performance and competitiveness.
- Improved Adjusted EBITDA: The adjusted EBITDA reached $11.5 million, up 62% year-over-year, reflecting significant enhancements in cost control and operational efficiency, bolstering confidence in future profitability.
- Strong Membership Growth: Canna Cabana membership grew to 2.58 million, a 47% increase year-over-year, while ELITE membership doubled to 162,000, showcasing the company's success in customer loyalty and market penetration.
- Positive Free Cash Flow: The company generated $2.9 million in free cash flow in Q1, a substantial improvement from negative $1.9 million in the same quarter last year, indicating a healthy shift in cash flow status and providing funding support for future investments and expansion.
See More
High Tide Reports Strong Q1 Earnings, Revenue Surges
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million for the three months ended January 31, 2026, reflecting a 25.2% year-over-year increase and exceeding market expectations by $51.47 million, demonstrating the company's ability to sustain growth in a competitive market.
- Record Gross Profit: The gross profit for the quarter reached $44.4 million, up 25% year-over-year and 4% sequentially, with a gross margin of 25%, indicating ongoing improvements in cost control and sales efficiency.
- Substantial Free Cash Flow Improvement: The company generated $2.9 million in free cash flow in Q1, a significant turnaround from $(1.9) million year-over-year and $1.3 million sequentially, enhancing its financial stability and operational flexibility.
- Net Loss Reduction: Although the company reported a net loss of $0.4 million in Q1, this marked a significant improvement from a net loss of $2.7 million year-over-year and $46.7 million sequentially, primarily due to reduced non-cash impairment expenses, indicating progress in profitability.
See More
High Tide (HITI) to Announce Q1 Earnings on March 17
- Earnings Announcement: High Tide (HITI) is set to release its Q1 2023 earnings report on March 17 after market close, with consensus EPS estimate at $0.00 and revenue estimate at $126.83 million, reflecting an 11% year-over-year decline.
- Historical Performance: Over the past two years, HITI has beaten EPS estimates 25% of the time while achieving a 100% success rate in beating revenue estimates, indicating strong revenue reliability.
- Market Volatility Impact: Despite reporting strong Q4 2025 results, the ongoing volatility in the cannabis sector poses challenges for High Tide's future financial performance, potentially affecting investor confidence.
- Investment Strategy Insight: High Tide's strategy of selling cash-secured puts for income investing is viewed as effective, yet market caution regarding its future performance necessitates close attention to the upcoming earnings report to assess the company's outlook.
See More
High Tide Opens New Store in Ontario, Expanding Market Reach
- New Store Opening: High Tide's Canna Cabana retail store in Sarnia, Ontario, is set to open on March 9, 2026, marking the company's entry into this market and increasing its total store count to 220 across Canada.
- Market Positioning: Located on London Road near Lambton Mall, the new store offers excellent visibility and is expected to attract local consumers seeking value and a diverse shopping experience, thereby enhancing the company's competitive edge.
- Financial Results Release: High Tide will release its financial and operational results for the quarter ending January 31, 2026, on March 17, 2026, followed by a webcast on March 18 to discuss the results and future outlook, further boosting investor confidence.
- Ongoing Expansion Strategy: Founder Raj Grover emphasized that despite having 220 stores, there are still significant organic growth opportunities, and the company will continue to focus on data-driven site selection strategies to support long-term growth.
See More
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive program as a supplier of eligible CBD products, marking a significant step toward integrating CBD into healthcare models.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the program's compliance requirements, thereby enhancing its competitive position in the market.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per beneficiary, which is expected to create significant market opportunities for NuLeaf and drive growth in its U.S. CBD business.
- Strategic Collaboration: NuLeaf's founding membership in the National Compassionate Care Council further solidifies its strategic position in advancing evidence-based cannabinoid policy and improving patient access to cannabinoid therapies.
See More
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive pilot program as a supplier of eligible CBD products, marking a strategic expansion into the healthcare market that is expected to drive growth in High Tide's U.S. CBD business.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the compliance requirements of the pilot program, thereby enhancing its competitiveness within the healthcare sector.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per year, which is anticipated to create new revenue streams for NuLeaf and increase its market share.
- Industry Impact: The launch of this program is viewed as a historic moment for the U.S. CBD industry, potentially improving treatment options for millions of Medicare beneficiaries and further solidifying NuLeaf's leadership position in the sector.
See More
High Tide Reports Strong Q1 Earnings with 25% Revenue Growth
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million, a 25% year-over-year increase, marking the fastest growth rate in the past 10 quarters, indicating strong market performance and competitiveness.
- Improved Adjusted EBITDA: The adjusted EBITDA reached $11.5 million, up 62% year-over-year, reflecting significant enhancements in cost control and operational efficiency, bolstering confidence in future profitability.
- Strong Membership Growth: Canna Cabana membership grew to 2.58 million, a 47% increase year-over-year, while ELITE membership doubled to 162,000, showcasing the company's success in customer loyalty and market penetration.
- Positive Free Cash Flow: The company generated $2.9 million in free cash flow in Q1, a substantial improvement from negative $1.9 million in the same quarter last year, indicating a healthy shift in cash flow status and providing funding support for future investments and expansion.
See More
High Tide Reports Strong Q1 Earnings, Revenue Surges
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million for the three months ended January 31, 2026, reflecting a 25.2% year-over-year increase and exceeding market expectations by $51.47 million, demonstrating the company's ability to sustain growth in a competitive market.
- Record Gross Profit: The gross profit for the quarter reached $44.4 million, up 25% year-over-year and 4% sequentially, with a gross margin of 25%, indicating ongoing improvements in cost control and sales efficiency.
- Substantial Free Cash Flow Improvement: The company generated $2.9 million in free cash flow in Q1, a significant turnaround from $(1.9) million year-over-year and $1.3 million sequentially, enhancing its financial stability and operational flexibility.
- Net Loss Reduction: Although the company reported a net loss of $0.4 million in Q1, this marked a significant improvement from a net loss of $2.7 million year-over-year and $46.7 million sequentially, primarily due to reduced non-cash impairment expenses, indicating progress in profitability.
See More
High Tide (HITI) to Announce Q1 Earnings on March 17
- Earnings Announcement: High Tide (HITI) is set to release its Q1 2023 earnings report on March 17 after market close, with consensus EPS estimate at $0.00 and revenue estimate at $126.83 million, reflecting an 11% year-over-year decline.
- Historical Performance: Over the past two years, HITI has beaten EPS estimates 25% of the time while achieving a 100% success rate in beating revenue estimates, indicating strong revenue reliability.
- Market Volatility Impact: Despite reporting strong Q4 2025 results, the ongoing volatility in the cannabis sector poses challenges for High Tide's future financial performance, potentially affecting investor confidence.
- Investment Strategy Insight: High Tide's strategy of selling cash-secured puts for income investing is viewed as effective, yet market caution regarding its future performance necessitates close attention to the upcoming earnings report to assess the company's outlook.
See More
High Tide Opens New Store in Ontario, Expanding Market Reach
- New Store Opening: High Tide's Canna Cabana retail store in Sarnia, Ontario, is set to open on March 9, 2026, marking the company's entry into this market and increasing its total store count to 220 across Canada.
- Market Positioning: Located on London Road near Lambton Mall, the new store offers excellent visibility and is expected to attract local consumers seeking value and a diverse shopping experience, thereby enhancing the company's competitive edge.
- Financial Results Release: High Tide will release its financial and operational results for the quarter ending January 31, 2026, on March 17, 2026, followed by a webcast on March 18 to discuss the results and future outlook, further boosting investor confidence.
- Ongoing Expansion Strategy: Founder Raj Grover emphasized that despite having 220 stores, there are still significant organic growth opportunities, and the company will continue to focus on data-driven site selection strategies to support long-term growth.
See More
